SkinBioTherapeutics PLC on Tuesday said its newly acquired Dermatonics will launch Pheet and Dermatonics Once Heel balm in Asia, the Middle East and Africa.
The Newcastle, England-based life science company focused on skin health on Tuesday said the launch will take place in partnership with Umesh Modi Group after they signed a manufacturing and distribution deal back in June.
Pheet and Dermatonics products are used for the treatment of dry foot skin and are sold under the Dermatonics brand in the rest of the world.
The Once Heel Balm product will be manufactured by Umesh Modi and sold directly by its sales team across six countries including India, Bangladesh Sri Lanka and Nigeria.
The total addressable market in these regions for dermatology and diabetes management is in excess of £5 billion, SkinBio said.
Dermatonics founder Greg Andrell said: ‘We have been working on this project for several months now and the launch of our brands is the end result of a lot of detailed preparation. We are excited by the potential opportunity of building sales in these rapidly growing regions.’
Shares in SkinBio were up 2.4% at 10.65 pence each in London on Tuesday afternoon.
Copyright 2024 Alliance News Ltd. All Rights Reserved.
